Increased copy numbers of NAGS, CPS1, and citrin genes and/or activating sequence variants could result in higher activity of the three proteins in glioblastoma, glioblastoma multiforme, lung adenocarcinoma, and stomach adenocarcinoma. This evidence concerns the gene SLC25A13 and glioblastoma.